LabConnect Introduces SampleGISTICS® 2.0 to Transform Clinical Sample Capture Process

LabConnect Revolutionizes Clinical Trials with SampleGISTICS® 2.0

In an impressive move to enhance the efficiency of clinical trials, LabConnect has launched SampleGISTICS® 2.0, a state-of-the-art mobile application that fundamentally updates the process of sample management in clinical research settings. This innovative solution replaces outdated digital pen technology, creating a seamless workflow for research facilities that need to manage a large number of participant samples accurately and efficiently.

Founded on the extensive experience of LabConnect in handling millions of samples from clinical trials worldwide, SampleGISTICS® 2.0 aims to eliminate the longstanding issues associated with paper-based requests, manual data entry, and disjointed communication processes. Such deficiencies have often led to the loss of samples, significant delays in shipments, and limited operational oversight.

Wes Wheeler, CEO of LabConnect, remarked, "SampleGISTICS® 2.0 embodies over two decades of expertise in decentralized clinical trial management through our global network of laboratories, couriers, and operational strategies. This experience has enabled us to create a new application specifically designed for clinical trials, digitalizing the capture of samples right at the point of collection."

The mobile application offers clinical research centers a fast and user-friendly method to handle sample collections, requests, and shipment tracking using a smartphone or tablet. With features like barcode scanning, multilingual support, and offline functionality, SampleGISTICS® 2.0 is built to ensure consistent performance across varying research environments. This not only facilitates same-day data collection but also enhances protocol adherence.

Diverging from traditional workflows that often rely on periodic status updates, the new app provides real-time visibility of sample location, condition, and stability, from collection point to laboratory entry. Guided workflows within the app adhere to study protocols, reducing data entry errors and ensuring the correct use of kits, which streamlines shipping and laboratory processes.

Charles Castano, Chief Technology Officer at LabConnect, explained, "SampleGISTICS® 2.0 simplifies the way centers manage study visit data and participant information at the sample collection point, securely transferring it to LabConnect’s validated LIMS environment. By leveraging technology to optimize data capture in the center, we can significantly reduce queries and gain visibility into samples nearing expiration that require priority processing. This also minimizes manual steps, provides immediate traceability of samples, enables real-time data capture, and supports faster and more reliable laboratory results."

The launch of SampleGISTICS® 2.0 marks an important milestone for LabConnect and the clinical trials industry. It emphasizes the need for innovative solutions to modernize sample management, ensuring accuracy, efficiency, and reliability in clinical research.

For further insights into LabConnect’s offerings and the new SampleGISTICS® 2.0, visit LabConnect.com.

About LabConnect

LabConnect is a global provider of centralized laboratory services equipped with advanced technology and functional service solutions for pharmaceutical, biotechnology, and contract research organizations. The company connects laboratories, logistics, technology, and scientific expertise through a decentralized laboratory network model to support clinical trials worldwide. To learn more, visit LabConnect.com.